Clearmind Medicine eyes 51% stake in EV wireless charging firm

August 3, 2026 8:02 AM

Clearmind Medicine Inc. (NASDAQ: CMND), a clinical-stage biotech company, has signed a non-binding letter of intent to acquire a 51 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found